Press material

Cilian receives major grant for enzyme replacement therapy with Ciliate-Lipase

26. July 2023

Transmissions between mammals demonstrate the serious dangerousness that mutations of avian influenza viruses might lead to an epidemic or pandemic for humans

8. May 2023

Press release: Bird flu threat calls for new vaccine technology

21. February 2023

Publications

Video: CIBEX System - Ciliate based expression system - The ciliated protozoan Tetrahymena as expression platform for the production of biopharmaceuticals

27. July 2023

Dr. Ingo Aldag, microbiologist at Cilian AG, presented a scientific poster on ciliate lipase at the Digestive Disease Week (DDW)

8. May 2023

Long term follow‑up of a simplified and less burdened pancreatic duct ligation model of exocrine pancreatic insufficiency in Goettingen Minipigs

8. May 2020

In the media

German working group of Pancreasectomized persons, reports on Cililan’s Lipase Development Cilase in newsletter: “Good in-vivo efficacy – Members encouraged to participate in clinical study”.

12. December 2022

Coronavirus: A globalised world needs globalised medicine

10. March 2020

Lokalzeit aktuell - New process to produce vaccines

12. February 2020

Contact us

Contact us with any questions and find information on how to contact us. We would like to hear from you!

Cilian AG

Experts for viral vaccines, digestive enzymes and cancer immunotherapy monoclonal antibodies with the most modern production and development technology.

Johann-Krane-Weg 42
48149 Münster, Germany

phone: +49 251 6 20 31 -0
fax: +49 251 6 20 31 -16
e-mail: info@cilian.de

Technology

Products

About us

Legal

Social Media